DPLO - Diplomat Pharmacy, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue4,485,2304,410,3883,366,631
Cost of Revenue4,136,5524,085,5603,103,392
Gross Profit348,678324,828263,239
Operating Expenses
Research Development---
Selling General and Administrative330,113277,751217,302
Non Recurring---
Total Operating Expenses---
Operating Income or Loss18,56547,07745,937
Income from Continuing Operations
Total Other Income/Expenses Net213370308
Earnings Before Interest and Taxes18,77842,78846,245
Interest Expense10,7166,5735,239
Income Before Tax8,06236,21541,006
Income Tax Expense-7,12611,19516,234
Minority Interest-3223,575
Net Income From Continuing Ops15,51023,61425,776
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income15,51028,27325,776
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares15,51028,27325,776